Ataxin-10 Antibodies

Santa Cruz Biotechnology delivers a wide array of Ataxin-10 monoclonal antibodies for research in understanding Ataxin-10's role in various cellular processes. Ataxin-10 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Ataxin-10 is associated with spinocerebellar ataxia type 10, a neurodegenerative disorder characterized by progressive loss of coordination and balance. Ataxin-10 plays a crucial role in RNA metabolism and cellular stress response, making it significant for understanding the underlying mechanisms of neurodegeneration. Studying Ataxin-10 can reveal potential therapeutic targets for treating related disorders. Researchers can explore the molecular pathways involved in neurodegenerative conditions through detailed analysis of Ataxin-10 expression and interactions. Understanding Ataxin-10's function in cellular processes may lead to breakthroughs in treating neurological disorders. Investigating Ataxin-10's role in RNA processing could uncover new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing neurobiology knowledge and developing potential treatments for neurodegenerative conditions.